Baker David W, Brown Tiffany, Goldman Shira N, Liss David T, Kollar Stephanie, Balsley Kate, Lee Ji Young, Buchanan David R
Division of General Internal Medicine and Geriatrics, Department of Medicine, Feinberg School of Medicine, Northwestern University, 750 N. Lake Shore Drive, 10th Floor, Chicago, IL, 60611, USA.
Center for Advancing Equity in Clinical Preventive Services, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Cancer Causes Control. 2015 Nov;26(11):1685-90. doi: 10.1007/s10552-015-0650-0. Epub 2015 Sep 4.
We previously found that a multifaceted outreach intervention achieved 82 % annual adherence to colorectal cancer (CRC) screening with fecal occult blood testing (FOBT). This study assessed adherence to FOBT after a second outreach.
We followed 225 patients in community health centers in Chicago, Illinois, who were randomized to the intervention group. Our primary analysis focused on 124 patients who completed FOBT during the first outreach and were due again for annual FOBT; 90% were Latino, 87% preferred to speak Spanish, and 77% were uninsured. Second outreach consisted of (1) a mailed reminder letter, a free fecal immunochemical test (FIT) with postage-paid return envelope, (2) automated phone and text messages, (3) automated reminders 2 weeks later if the FIT was not returned, and (4) a telephone call after 3 months. Our main outcome was completion of FIT within 6 months of the due date. We also analyzed the proportion of the original 225 patients who were fully screened for CRC over the 2-year study period.
A total of 88.7% of patients completed a FIT within 6 months of their second outreach. Over the 2 years since the first outreach, 71.6% of the 225 patients assigned to the intervention group were fully up to date on CRC screening, another 11.1% had been screened suboptimally, and 17.3% were inadequately screened or not screened.
It is possible to achieve high rates of CRC screening over a 2-year period for vulnerable populations using outreach with FIT as a primary strategy.
我们之前发现,一项多方面的推广干预措施使粪便潜血试验(FOBT)用于结直肠癌(CRC)筛查的年依从率达到了82%。本研究评估了第二次推广后对FOBT的依从性。
我们对伊利诺伊州芝加哥社区卫生中心的225名患者进行了随访,这些患者被随机分配到干预组。我们的主要分析集中在124名在第一次推广期间完成FOBT且应再次进行年度FOBT的患者;其中90%为拉丁裔,87%更喜欢说西班牙语,77%没有保险。第二次推广包括:(1)一封邮寄的提醒信、一份附带邮资已付回邮信封的免费粪便免疫化学检测(FIT);(2)自动电话和短信;(3)如果FIT未返回,两周后自动提醒;(4)三个月后进行电话随访。我们的主要结局是在应检日期的6个月内完成FIT检测。我们还分析了在为期2年的研究期间,最初225名患者中接受CRC全面筛查的比例。
在第二次推广后的6个月内,共有88.7%的患者完成了FIT检测。自第一次推广后的两年里,分配到干预组的225名患者中,71.6%的患者CRC筛查完全达标,另有11.1%的患者筛查情况欠佳,17.3%的患者筛查不充分或未接受筛查。
以FIT作为主要策略进行推广,有可能在两年内使弱势群体的CRC筛查率达到较高水平。